Adriaens E, Remon JP (2008) Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis 35:512–516
Article CAS PubMed Google Scholar
Agace WW, Amara A, Roberts AI, Pablos JL, Thelen S, Uguccioni M, Li XY, Marsal J, Arenzana-Seisdedos F, Delaunay T, Ebert EC, Moser B, Parker CM (2000) Constitutive expression of stromal derived factor-1 by mucosal epithelia and its role in HIV transmission and propagation. Curr Biol 23:325–328
Arnold KB, Burgener A, Birse K, Romas L, Dunphy LJ, Shahabi K, Abou M, Westmacott GR, McCorrister S, Kwatampora J, Nyanga B, Kimani J, Masson L, Liebenberg LJ, Abdool Karim SS, Passmore JA, Lauffenburger DA, Kaul R, McKinnon LR (2016) Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells. Mucosal Immunol 9:194–205
Article CAS PubMed Google Scholar
Ayehunie S, Cannon C, Lamore S, Kubilus J, Anderson DJ, Pudney J, Klausner M (2006) Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and personal care products. Toxicol 20:689–698
Ayehunie S, Cannon C, Larosa K, Pudney J, Anderson DJ, Klausner M (2011) Development of an in vitro alternative assay method for vaginal irritation. Toxicology 279:130–138
Article CAS PubMed Google Scholar
Ayehunie S, Islam A, Cannon C, Landry T, Pudney J, Klausner M, Anderson DJ (2015) Characterization of a hormone-responsive organotypic human vaginal tissue model: morphologic and immunologic effects. Reprod Sci 22:980–990
Article CAS PubMed PubMed Central Google Scholar
Ayehunie S, Wang YY, Landry T, Bogojevic S, Cone RA (2017) Hyperosmolal vaginal lubricants markedly reduce epithelial barrier properties in a three-dimensional vaginal epithelium model. Toxicol Rep 16:134–140
Bakus C, Budge KL, Feigenblum N, Figueroa M, Francis AP (2023) The impact of contraceptives on the vaginal microbiome in the non-pregnant state. Front Microbiomes 1:1–9
Baldeon-Vaca G, Marathe JG, Politch JA, Mausser E, Pudney J, Doud J, Nador E, Zeitlin L, Pauly M, Moench TR, Brennan M, Whaley KJ, Anderson DJ (2021) Production and characterization of a human antisperm monoclonal antibody against CD52g for topical contraception in women. EBioMedicine 69:103478
Article CAS PubMed PubMed Central Google Scholar
Bélec L, Meillet D, Lévy M, Georges A, Tévi-Bénissan C, Pillot J (1995) Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diagn Lab Immunol 2:57–61
Article PubMed PubMed Central Google Scholar
Benson K, Cramer S, Galla HJ (2013) Impedance-based cell monitoring: barrier properties and beyond. Fluids Barriers CNS 10:1–11
Benziger DP, Edelson J (1983) Absorption from the vagina. Drug Metab Rev 14:137–168
Article CAS PubMed Google Scholar
Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B (2004) Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrob Agents Chemother 48:1837–1847
Article CAS PubMed PubMed Central Google Scholar
Clark MR, McCormick TJ, Doncel GF, Friend DR (2011) Preclinical evaluation of UC781 microbicide vaginal drug delivery. Drug Deliv Transl Res 1:175–182
Article CAS PubMed Google Scholar
Cohen J (2008) AIDS research. Microbicide fails to protect against HIV. Science 319:1026–1027
Article CAS PubMed Google Scholar
Cone R, Hoen T, Wong X, Abusuwwa R, Anderson D, Moench TR (2006) Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis 6:90
Article PubMed PubMed Central Google Scholar
Costin GE, Hill E, Brown J, Clippinger AJ (2020) Qualification of a non-animal vaginal irritation method admitted as nonclinical assessment model (NAM) in the Incubator Phase of the United States Food and Drug Administration (US FDA) Medical Devices Development Tool (MDDT). Toxicol in Vitro 62:104680
Costin GE, Raabe HA, Priston R, Evans E, Curren RD (2011) Vaginal irritation models: The current status of available alternative and in vitro tests. ATLA Altern to Lab Anim 39:317–337
D’cruz OJ, Erbeck D, Uckun FM (2005) A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol Pathol 33:465–476
Dayal MB, Wheeler J, Williams CJ, Barnhart KT (2003) Disruption of the upper female reproductive tract epithelium by nonoxynol-9. Contraception 68:273–279
Article CAS PubMed Google Scholar
Dhondt MM, Adriaens E, Remon JP (2004) The evaluation of the local tolerance of vaginal formulations, with or without nonoxynol-9, using the slug mucosal irritation test. Sex Transm Dis 31:229–235
Article CAS PubMed Google Scholar
Fatakdawala H, Uhland SA (2011) Hydrogen peroxide mediated transvaginal drug delivery. Int J Pharm 409:121–127
Article CAS PubMed Google Scholar
FDA (2023) Qualification of medical device development tools; Guidance for industry, tool developers, and food and drug administration staff. Document issued on July 17 by U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health
Fichorova RN, Anderson DJ (1999) Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 60:508–514
Article CAS PubMed Google Scholar
Fichorova RN, Tucker LD, Anderson DJ (2001) The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 184:418–428
Fink CG, Thomas GH, Allen JM, Jordan JA (1973) Metaplasia in endocervical tissue maintained in organ culture–an experimental model. J Obstet Gynaecol Br Commonw 80:169–175
Article CAS PubMed Google Scholar
Fuchs EJ, Lee LA, Torbenson MS, Parsons TL, Bakshi RP, Guidos AM, Wahl RL, Hendrix CW (2007) Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis 195:703–710
Galen BT, Martin AP, Hazrati E, Garin A, Guzman E, Wilson SS, Porter DD, Lira SA, Keller MJ, Herold BC (2007) A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety. J Infect Dis 195:1332–1339
Article CAS PubMed Google Scholar
Golińska E, Sowińska N, Tomusiak-Plebanek A, Szydło M, Witka N, Lenarczyk J, Strus M (2021) The vaginal microflora changes in various stages of the estrous cycle of healthy female dogs and the ones with genital tract infections. BMC Vet Res 17:1–8
Grant-Tschudy KS, Wira CR (2004) Effect of estradiol on mouse uterine epithelial cell transepithelial resistance (TER). Am J Reprod Immunol 52:252–262
Hearps A, Tyssen D, Srbinovski D, Bayigga L, Diaz DJD, Aldunate M, Cone RA, Gugasyan R, Anderson DJ, Tachedjian G (2017) Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition. Mucosal Immunol 10:1480–1490
Article CAS PubMed Google Scholar
Hjelm BE, Berta AN, Nickerson CA, Arntzen CJ, Herbst-Kralovetz MM (2010) Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biol Reprod 82:617–627
Article CAS PubMed PubMed Central Google Scholar
Imagawa W, Pedchenko VK, Helber J, Zhang H (2002) Hormone/growth factor interactions mediating epithelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 80:213–230
Comments (0)